0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Antibodies - Volume 2: Novel Technologies and Therapeutic Use (Paperback, Softcover reprint of the original 1st ed. 2004) Loot Price: R2,641
Discovery Miles 26 410
Antibodies - Volume 2: Novel Technologies and Therapeutic Use (Paperback, Softcover reprint of the original 1st ed. 2004): G....

Antibodies - Volume 2: Novel Technologies and Therapeutic Use (Paperback, Softcover reprint of the original 1st ed. 2004)

G. Subramanian

 (sign in to rate)
Loot Price R2,641 Discovery Miles 26 410 | Repayment Terms: R248 pm x 12*

Bookmark and Share

Expected to ship within 18 - 22 working days

It is now over one hundred years since von Behring and Kitsato first concluded experiments that led to the use of passive immunisation, employing antibodies raised in animals against tetanus and diphtheria toxins. The advancement of technology both in manufacturing purity product in a cost effective way and the clinical research has proved that antibodies are one ofthe most successful products in biotechnology. Monoclonal antibodies account for between one-third and one-halfof all pharmaceutical products in development and human clinical trials. Both the nature of monoclonal antibody therapies and the relatively large size of the monoclonal antibody dictate the production requirements, for many ofthese therapeutics the monoclonal antibody product will be 100 kilogrammes or more per year. It is widely acknowledged that there is currently a worldwide shortage of biomanufacturing capacity, and the active pharmaceutical ingredient material requirements for these products are expected to increase. Thus the industry is looking for new sources and extensive studies are being carried out not only for alternative technology to meet the needs but also to reveal the new therapeutic applicationsofantibodies. This book brings to the forefront current advances in novel technologies for the manufacturing of monoclonal antibodies and also their extensive clinical importance. The first four chapters give an overview of the new technologies and the successful application in the manufacture of monoclonal antibodies with clinical purity. The next chapters address the application of antibodies in cancer therapy and functional genomic therapy.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: November 2012
First published: 2004
Editors: G. Subramanian
Dimensions: 235 x 155 x 13mm (L x W x T)
Format: Paperback
Pages: 232
Edition: Softcover reprint of the original 1st ed. 2004
ISBN-13: 978-1-4613-4702-6
Categories: Books > Medicine > Nursing & ancillary services > Pharmacy / dispensing
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Nursing & ancillary services > Biomedical engineering > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
Promotions
LSN: 1-4613-4702-5
Barcode: 9781461347026

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners